跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
6-f
首页
药物
6-f
6-f
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMINE AND METHODS OF MAKING
EP 4302761 A3
申请人: BLUEPRINT MEDICINES CORP
优先权: 2019
EP
US
WO
11 件公开
TERT-BUTYL 2-(4-PHENYL-6H-THIENO[3,2-F][1,2,4]TRIAZOLO[4,3-A] [1,4]DIAZEPIN-6-YL) ACETATE DERIVATIVES AS BROMODOMAIN BRD4 INHIBITORS FOR TREATING CANCER
EP 4342543 C0
申请人: HOFFMANN LA ROCHE
优先权: 2018
CN
EP
US
WO
7 件公开
METHOD OF PREPARING SOLID FORMS OF SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS
EP 4019499 A1
申请人: ARQULE INC
优先权: 2015
CN
EP
US
5 件公开
METHODS FOR PREPARING SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE
EP 4015508 A1
申请人: ARQULE INC
优先权: 2015
CN
EP
US
4 件公开
Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
US 2006235020 A1
申请人: KIM SOOJIN
优先权: 2006
CN
US
4 件公开
Crystalline forms of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
US 2007088035 A1
申请人: BRISTOL MYERS SQUIBB CO
优先权: 2006
CN
US
4 件公开
Process for preparing (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino) ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
US 8039628 B2
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2005
US
4 件公开
Peptide-lipid constructs and their use in diagnostic and therapeutic applications
US 8394594 B2
申请人: WEINBERG CRISTINA-SIMONA
优先权: 2007
US
4 件公开
Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide
EP 2053052 A1
申请人: ESTEVE LABOR DR
优先权: 2007
CN
EP
US
3 件公开
PESTICIDAL MIXTURES COMPRISING A PYRAZOLE COMPOUND
EP 3646731 A1
申请人: BASF SE
优先权: 2012
CN
EP
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈